Abstract
The aim of this study was to evaluate clinical characteristics, procedural details, and outcomes of patients undergoing elective multivessel percutaneous coronary intervention (MV-PCI) in Europe. A total of 7113 patients with stable coronary artery disease and at least two major epicardial vessels with ≥70% stenosis were included in this analysis of the contemporary Euro Heart Survey PCI registry. Patients undergoing MV-PCI (n = 3376, 47.5%) were compared with those with single-vessel PCI (SV-PCI) (n = 3737, 52.5%). Patients with MV-PCI were more likely to have congestive heart failure, whereas those with SV-PCI more often suffered from noncardiac comorbidities. Hospital mortality (0.1% vs 0.3%) and the incidence of nonfatal postprocedural myocardial infarction (1.0% vs 0.7%) were low in patients with MV-PCI and SV-PCI. In the multivariate analysis, no significant difference in the incidence of hospital death (odds ratio (OR) 0.44, 95% confidence interval (CI) 0.15–1.27) could be observed between the two groups. However, the risk for postprocedural myocardial infarction (OR 1.57, 95% CI 0.93–2.67) tended to be higher among patients undergoing MV-PCI. Independent determinants for performing MV-PCI were age, comorbidities, and coronary anatomy. In Europe almost half of all patients with multivessel disease were treated with MV-PCI. Hospital complications were low, but a trend toward a higher rate of postprocedural myocardial infarctions was seen in patients with MV-PCI.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Grüntzig A (1978) Transluminal dilatation of coronary-artery stenosis. Lancet 1:263
Higashitani M, Mori F, Yamada N, Arashi H, Kojika A, Hoshi H, Minami Y, Yamaguchi J, Yamauchi T, Takagi A, Ogawa H, Hagiwara N (2011) Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients. Heart Vessels. doi:10.1007/s00380-010-0110-4
Pepe M, Napodano M, Tarantini G, Fraccaro C, Cutolo A, Peluso D, Isabella G, Ramondo A, Iliceto S (2011) Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents. Heart Vessels 26:17–24
Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB (2003) A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 41:1293–1304
Thiele H, Oettel S, Jacobs S, Hambrecht R, Sick P, Gummert JF, Mohr FW, Schuler G, Falk V (2005) Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: a 5-year follow-up. Circulation 112:3445–3450
Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, Carrié D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kähler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ (2009) Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 373:1190–1197
Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360:961–972
Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm CW, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W (2005) Guidelines for percutaneous coronary interventions. Eur Heart J 26:804–847
Onuma Y, Kukreja N, Ramcharitar S, Hochadel M, Gitt A, Serruys P (2009) Interventional treatment in diabetics in the era of drug-eluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey Programme. EuroIntervention 4:578–587
Ramcharitar S, Hochadel M, Gaster AL, Onuma Y, Gitt A, Serruys PW (2008) An insight into the current use of drug eluting stents in acute and elective percutaneous coronary interventions in Europe. A report on the EuroPCI Survey. EuroIntervention 3:429–441
Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte op Reimer WJ, Mercado N, Wijns W (2005) Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J 26:1169–1179
Goldman LE, Okrainec K, Eisenberg MJ, Schechter D, Lefkovits J, Goudreau E, Deligonul U, Mak KH, Del Core M, Duerr R, Huynh T, Smilovitch M, Sedlis S, Brown DL, Brieger D, ROSETTA Investigators (2004) Six-month outcomes after single- and multi-lesion percutaneous coronary intervention: results from the ROSETTA registry. Can J Cardiol 20:608–612
Kornowski R, Mehran R, Satler LF, Pichard AD, Kent KM, Greenberg A, Mintz GS, Hong MK, Leon MB (1999) Procedural results and late clinical outcomes following multivessel coronary stenting. J Am Coll Cardiol 33:420–426
Chauhan A, Vu E, Ricci DR, Buller CE, Moscovich MD, Monkman S, Penn IM (1998) Early and intermediate term clinical outcome after multiple coronary stenting. Heart 79:29–33
Hernández-Antolin RA, Alfonso F, Goicolea J, Pérez-Vizcayno MJ, Bañuelos C, Fernández-Ortiz A, Escaned J, Azcona L, Rodriguez A, Fernández C, Macaya C (1999) Results (>6 months) of stenting of >1 major coronary artery in multivessel coronary artery disease. Am J Cardiol 84:147–151
Laham RJ, Ho KK, Baim DS, Kuntz RE, Cohen DJ, Carrozza JP Jr (1997) Multivessel Palmaz-Schatz stenting: early results and one-year outcome. J Am Coll Cardiol 30:180–185
Mathew V, Rihal CS, Berger PB, Bell MR, Garratt KN, Holmes R Jr (1998) Clinical outcome of patients undergoing multivessel coronary stent implantation. Int J Cardiol 64:1–7
Orlic D, Bonizzoni E, Stankovic G, Airoldi F, Chieffo A, Corvaja N, Sangiorgi G, Ferraro M, Briguori C, Montorfano M, Carlino M, Colombo A (2004) Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results. J Am Coll Cardiol 43:1154–1160
Nienhuis MB, Ottervanger JP, Dambrink JH, Dikkeschei LD, Suryapranata H, van’t Hof AW, Hoorntje JC, de Boer MJ, Gosselink AT, Zijlstra F (2007) Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention. Neth Heart J 15:178–183
Ijsselmuiden AJ, Ezechiels J, Westendorp IC, Tijssen JG, Kiemeneij F, Slagboom T, van der Wieken R, Tangelder G, Serruys PW, Laarman G (2004) Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. Am Heart J 148:467–474
Shishehbor MH, Topol EJ, Mukherjee D, Hu T, Cohen DJ, Stone GW, McClure R, Roffi M, Moliterno DJ (2006) Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. Am J Cardiol 97:1585–1590
Author information
Authors and Affiliations
Corresponding author
Additional information
ESC Expert Committee for the PCI registry of the Euro Heart Survey Programme 2006–2008: Jean Marco (Chairperson) (Monaco), Anselm K. Gitt (co-Chairperson) (Germany), Franz Eberli (Switzerland), Ricardo Seabra-Gomes (Portugal), Patrick Serruys (Netherlands), Sigmund Silber (Germany), Alec Vahanian (France), Franz Weidinger (Austria), Williams Wijns (Belgium), Uwe Zeymer (Germany).
Rights and permissions
About this article
Cite this article
Bauer, T., Möllmann, H., Zeymer, U. et al. Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry. Heart Vessels 27, 453–459 (2012). https://doi.org/10.1007/s00380-011-0207-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-011-0207-4